| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/17/2008 | EP0909317B1 Compositions for modulating the length of telomeres |
| 12/17/2008 | CN101323860A Novel biological method for detoxification |
| 12/17/2008 | CN101322847A Anti-hepatitis b virus gene medicament based on siRNA pool interference and mediated by complex carrier |
| 12/17/2008 | CN101322846A Compositions containing inclusion complexes |
| 12/17/2008 | CN100443593C Methods for stable transduction of cells with viral vectors |
| 12/16/2008 | US7465794 genetic engineered RNA viruses that express immunology modulators such as cytokines, chemokines, enzymes, cytokine and chemokine antagonist, surface receptors, adhesion molecule or ligands; genetic vaccines |
| 12/16/2008 | US7465716 Targeted drug delivery with a hyaluronan ligand |
| 12/16/2008 | US7465707 Methods of treatment with TR10 polypeptides |
| 12/16/2008 | US7465705 Immunogenic Nogo receptor-1 polypeptides, Nogo receptor-1 antibodies; diabetic neuropathy; brain injury, spinal cord injury |
| 12/16/2008 | US7465583 Comprising adeno-associated virus terminal repeat sequences; intrastrand base-pairing |
| 12/16/2008 | US7465580 vector encoding a derivative of EBNA-1 that is not cytotoxic when expressed efficiently in cells, which supports extrachromosomal replication, maintenance and transcription from extrachromosomal oriP containing vectors but does not substantially activate transcription from host cell genes |
| 12/16/2008 | US7465554 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof |
| 12/16/2008 | US7465553 Psoriasin expression by breast epithelial cells |
| 12/16/2008 | US7465548 associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, urological diseases, respiratory diseases and gastroenterological diseases |
| 12/16/2008 | US7465443 Acellular antibordetella vaccine |
| 12/16/2008 | US7465442 Reduction of dermal scarring |
| 12/16/2008 | US7465441 Using interleukins, immunoglobulin fusion; genetic engineering; signaling |
| 12/16/2008 | CA2298018C Methods and compositions for inhibiting angiogenesis |
| 12/16/2008 | CA2285667C Viral vectors having chimeric envelope proteins containing the igg-binding domain of protein a |
| 12/16/2008 | CA2254975C Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
| 12/16/2008 | CA2253632C Compositions and methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna |
| 12/16/2008 | CA2239692C Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 12/11/2008 | WO2008150814A2 Methods for production and uses of multipotent cell populations |
| 12/11/2008 | WO2008148304A1 Rna interference target for treating aids |
| 12/11/2008 | WO2008148216A1 Drak2 expression is associated with diabetes |
| 12/11/2008 | WO2008148215A1 Estrogen receptor-related receptor gamma (err gamma) in bone and cartilage formation and methods and compositions relating to same |
| 12/11/2008 | WO2008110356A3 Protein pi 16 secreted from the heart and uses thereof |
| 12/11/2008 | WO2008101219A3 Compositions and methods for inhibiting or reversing fibrotic disorders |
| 12/11/2008 | WO2008092142A3 Rnai-mediated inhibition of aquaporin 1 for treatment of ocular neovascularization |
| 12/11/2008 | WO2008088875A3 Method of treating hepatitis c virus |
| 12/11/2008 | WO2008054826A3 Pathotropic targeted gene delivery system for cancer and other disorders |
| 12/11/2008 | WO2008052770A3 (base-)modified rna for increasing the expression of a protein |
| 12/11/2008 | WO2007103048A3 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity |
| 12/11/2008 | WO2007100892A3 Trojan horse immunotherapy |
| 12/11/2008 | US20080306015 Using RNA interference to treat and prevent diabetes, alzheimer's, cancer disorders; antisense agents |
| 12/11/2008 | US20080305999 Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia |
| 12/11/2008 | US20080305543 RNA interference pathway genes as tools for targeted genetic interference |
| 12/11/2008 | US20080305490 Amplification of human mdm2 gene in human tumors |
| 12/11/2008 | US20080305181 Compositions and Methods for Treatment of Vascular Grafts |
| 12/11/2008 | US20080305131 Cancer Immunotherapy with Semi-Allogeneic Cells |
| 12/11/2008 | US20080305129 Highly Attenuated Pox Virus Strains, Method for the Production Thereof and the Use Thereof as Paramunity Inducers or For Producing Vector Vaccines |
| 12/11/2008 | US20080305112 raising an antibody specific for Chlamydia trachomatis elementary bodies (EB) in which a protein of the present invention is administered to a patient |
| 12/11/2008 | US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof |
| 12/11/2008 | US20080305109 Method of passive immunization |
| 12/11/2008 | US20080305102 Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer |
| 12/11/2008 | US20080305088 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 12/11/2008 | US20080305084 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions |
| 12/11/2008 | US20080305083 Gfap-based gene therapy for treatment of retinal diseases |
| 12/11/2008 | US20080305076 Method of inducing memory b cell development and terminal differentiation |
| 12/11/2008 | US20080305074 Stem cell factor |
| 12/11/2008 | US20080305073 Therapeutic Agents for the Treatment of Hmgb1-Related Pathologies |
| 12/11/2008 | CA2690848A1 Estrogen receptor-related receptor gamma (erry) in bone and cartilage formation and methods and compositions relating to same |
| 12/11/2008 | CA2689317A1 Antigen presenting cells |
| 12/11/2008 | CA2688032A1 Cd34 stem cell-related methods and compositions |
| 12/10/2008 | EP2000535A1 Circovirus sequences associated with porcine wasting disease (PWD) |
| 12/10/2008 | EP2000479A1 Genetic Sequences and Proteins Related to Alzheimer's Disease, and Uses Therefor |
| 12/10/2008 | EP1998811A2 Eimmunotherapy for immune suppressed patients |
| 12/10/2008 | EP1998797A1 Master gene of arteriogenesis |
| 12/10/2008 | EP1998794A2 Synthetic lipid rafts and methods of use |
| 12/10/2008 | EP1718659A4 Vectors having both isoforms of beta-hexosaminidase and uses of the same |
| 12/10/2008 | EP1608753B1 Antisense oligonucleotides (odn) against smad7 and uses in medical field thereof |
| 12/10/2008 | EP1606411B1 Mutant vesicular stomatitis viruses and use thereof |
| 12/10/2008 | EP1590001B1 Method for in vivo regulation of cardiac muscle contractility |
| 12/10/2008 | EP1520044B1 Chromosome 9 genes involved in premature canities |
| 12/10/2008 | EP1403284B1 HAb18G/CD147, ITS ANTAGONIST AND APPLICATION |
| 12/10/2008 | EP1220913B1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 12/10/2008 | EP1218525B1 Utrophin gene promoter |
| 12/10/2008 | EP1163342B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/10/2008 | EP1042350B1 Inducible phosphofructokinase and the warburg effect |
| 12/10/2008 | EP1021464B1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 12/10/2008 | EP0972054B1 Enhancement of immune response using targeting molecules |
| 12/10/2008 | CN101319229A Recombined human bFGF and PDGF-B duplicate adenovirus carrier and uses thereof |
| 12/10/2008 | CN101319228A Human BMP recombinant adenovirus containing carrier and construction method |
| 12/10/2008 | CN101319215A Human tumour specific Ki67 gene promotor |
| 12/10/2008 | CN101318018A Application of anti-aFGF-scFv in preparing antineoplastic medicament and preparation method thereof |
| 12/10/2008 | CN101318012A Application of beta-inhibited protein 1 in governing survival and autoimmunity of T cell |
| 12/10/2008 | CN100441689C EHEC 0157 shiga-like toxin IIA resisting subunit monoclonal antibody 5F3 light and heavy chain variable region gene and its application |
| 12/10/2008 | CN100441688C Lim mineralization protein splice variants |
| 12/10/2008 | CN100441687C Antisense oligonucleotide structure and use for inhibiting epidermal regulator EREG gene expression |
| 12/10/2008 | CN100441682C Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
| 12/10/2008 | CN100441241C Crosslinked hyaluronic acid compositions for tissue augmentation |
| 12/10/2008 | CN100441226C Method of speeding wound repair and preventing complications |
| 12/10/2008 | CN100441223C Human papilloma virus treatment |
| 12/09/2008 | US7462703 For use in gene therapy |
| 12/09/2008 | US7462603 Artificial micelle comprising shuttle vector for use as tool in efficient gene transfer to cells |
| 12/09/2008 | US7462592 Compositions and methods for polynucleotide delivery |
| 12/09/2008 | US7462483 p27 and p21 in gene therapies |
| 12/09/2008 | US7462466 Porcine CD59 nucleic acids and cells containing the same |
| 12/09/2008 | US7462357 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants |
| 12/09/2008 | US7462354 Storing a plurality of input parameters in a memory of a computer system, generating a list of epitope pairs from epitopes; determining for each epitope pairs at least one optimum combination of amino acid insertions; identifying |
| 12/09/2008 | US7462351 dextrin polymers in combination with sugars provide enhanced delivery of nucleic acids, particularly eucaryotic expression vectors, demonstrate enhanced delivery of nucleic acids to cells in vivo |
| 12/09/2008 | CA2183151C Host-vector system for use in gene therapy |
| 12/04/2008 | WO2008147430A2 Microrna-formatted multitarget interfering rna vector constructs and methods of using the same |
| 12/04/2008 | WO2008146854A1 Paratope and epitope of anti-mortalin antibody |
| 12/04/2008 | WO2008146841A1 Nucleic acid carrier for introduction of nucleic acid into cancer cell |
| 12/04/2008 | WO2008145685A1 Hpv polyepitope constructs and uses thereof |
| 12/04/2008 | WO2008145400A2 Mutated structural protein of a parvovirus |
| 12/04/2008 | WO2008144912A1 Antifolate agent-resistant dihydrofolate reductases |
| 12/04/2008 | WO2008125836A3 Methods and uses related to rhbdl4 |
| 12/04/2008 | WO2008103380A3 Hepatitis b virus compositions and methods of use |